High-density Contrast Agents Market

Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

High-density Contrast Agents Market contains market size and forecasts of High-density Contrast Agents in global, including the following market information:

Global High-density Contrast Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global High-density Contrast Agents Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five High-density Contrast Agents companies in 2021 (%)

The global High-density Contrast Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

X-ray and CT Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of High-density Contrast Agents include GE, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG and BeiLu Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the High-density Contrast Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global High-density Contrast Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global High-density Contrast Agents Market Segment Percentages, by Type, 2021 (%)

• X-ray and CT
• MRI
• Ultrasound

Global High-density Contrast Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global High-density Contrast Agents Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global High-density Contrast Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global High-density Contrast Agents Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies High-density Contrast Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies High-density Contrast Agents revenues share in global market, 2021 (%)
• Key companies High-density Contrast Agents sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies High-density Contrast Agents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GE
• Bayer
• Bracco Imaging
• Guerbet Group
• Hengrui Medicine
• Lantheus
• YRPG
• BeiLu Pharma